Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 14, 2014; 20(34): 12283-12291
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12283
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12283
Figure 2 Effect of otilonium bromide (20, 40, 80 mg) and placebo on the intensity (A) and frequency (B) of abdominal discomfort, bloating or pain.
Data are presented as % change from baseline values. Asterix denotes level of statistical significance (aP < 0.05) for placebo vs 80 mg otilonium bromide at 1 wk.
- Citation: Chmielewska-Wilkoń D, Reggiardo G, Egan CG. Otilonium bromide in irritable bowel syndrome: A dose-ranging randomized double-blind placebo-controlled trial. World J Gastroenterol 2014; 20(34): 12283-12291
- URL: https://www.wjgnet.com/1007-9327/full/v20/i34/12283.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i34.12283